Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer

Trial Profile

Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 May 2018

At a glance

  • Drugs Exemestane (Primary)
  • Indications Atypical endometrial hyperplasia; Endometrial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Mar 2018 Planned End Date changed from 1 Jan 2019 to 1 Dec 2018.
    • 13 Mar 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Dec 2018.
    • 22 Nov 2017 Planned End Date changed from 1 Oct 2018 to 1 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top